Autolus Therapeutics (AUTL) Receivables - Other (2017 - 2025)
Historic Receivables - Other for Autolus Therapeutics (AUTL) over the last 9 years, with Q3 2025 value amounting to $936000.0.
- Autolus Therapeutics' Receivables - Other rose 5652.17% to $936000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $936000.0, marking a year-over-year increase of 5652.17%. This contributed to the annual value of $1.4 million for FY2024, which is 17538.76% up from last year.
- Per Autolus Therapeutics' latest filing, its Receivables - Other stood at $936000.0 for Q3 2025, which was up 5652.17% from $665000.0 recorded in Q2 2025.
- Over the past 5 years, Autolus Therapeutics' Receivables - Other peaked at $2.4 million during Q3 2023, and registered a low of $384000.0 during Q4 2021.
- Its 5-year average for Receivables - Other is $948000.0, with a median of $736000.0 in 2024.
- Its Receivables - Other has fluctuated over the past 5 years, first surged by 27369.79% in 2022, then plummeted by 7462.88% in 2024.
- Quarter analysis of 5 years shows Autolus Therapeutics' Receivables - Other stood at $384000.0 in 2021, then surged by 273.7% to $1.4 million in 2022, then tumbled by 64.04% to $516000.0 in 2023, then skyrocketed by 175.39% to $1.4 million in 2024, then plummeted by 34.13% to $936000.0 in 2025.
- Its Receivables - Other was $936000.0 in Q3 2025, compared to $665000.0 in Q2 2025 and $423000.0 in Q1 2025.